Haloprogin

Haloprogin

Clinical data
Routes of administration	Topical
ATC code	D01AE11 (WHO)
Legal status
Legal status	US: Not available
Identifiers
IUPAC name 1,2,4-Trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene
CAS Number	777-11-7 Y
PubChem CID	3561
DrugBank	DB00793 Y
ChemSpider	3440 Y
UNII	AIU7053OWL
KEGG	D00339 Y
ChEMBL	CHEMBL1289 Y
ECHA InfoCard	100.011.169
Chemical and physical data
Formula	C9H4Cl3IO
Molar mass	361.39 g/mol
3D model (JSmol)	Interactive image
Melting point	113.5 °C (236.3 °F)
Solubility in water	Insoluble mg/mL (20 °C)
SMILES Clc1cc(OCC#CI)c(Cl)cc1Cl
InChI InChI=1S/C9H4Cl3IO/c10-6-4-8(12)9(5-7(6)11)14-3-1-2-13/h4-5H,3H2 Y Key:CTETYYAZBPJBHE-UHFFFAOYSA-N Y
(verify)

Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections. It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.

Action

Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over-the-counter primarily to treat tinea infections of the skin. The mechanism of action is unknown.^[1]

Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.^[2]

References

1. ↑ "Haloprogin". Drugs@FDA. Food and Drug Administration. Retrieved 2007-02-17. 
2. ↑ "Haloprogin". DrugBank. University of Alberta. Nov 6, 2006. Retrieved 2007-02-17.